News Archives - Page 150 of 702

FridayJun 23, 2023 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Expands Collaboration with NVIDIA, Releases New Financial Update Revealing Progress on Volume Production

Cepton integrated Vista-X120 Plus lidar into NVIDIA Omniverse platform to enable real-time simulation and 3D visualization to streamline lidar deployment processes and reduce cost for automakers Vista-X120 Plus features a software-definable ROI, allows users to dynamically adjust and optimize lidar performance and power consumption based on specific scenarios or areas that require additional attention Cepton released a financial update revealing it was on track to receive final production validation for salable vehicles and continue shipment of pre-production lidar units for multiple vehicle models Additional update highlights included completed implementation of embedded lidar software, and execution of RFQ and RFI responses…

ThursdayJun 22, 2023 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Findings in Diabetes Animal Study and Two Other R&D Programs

Diabetes – Blood glucose levels reduced by 19.9% with patented DehydraTECH(TM) processed CBD Epilepsy – Lower dosages of DehydraTECH-CBD were needed to achieve the same results of Epidiolex(R) in the company’s animal epilepsy study Dementia – Lexaria determined that a longer testing duration is needed for DehydraTECH-CBD in cognition studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, including the company’s patented DehydraTECH(TM) technology, recently reported additional findings from its diabetes animal study DIAB-A22-1, as well as updates on two other applied R&D programs for dementia (DEM-A22-1) and epilepsy (EPIL-A21-1). In March, Lexaria announced that it had…

ThursdayJun 22, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Gains Exclusive Development and Commercialization License from Max Planck for biobetter Anti-IL-17 Antibody

BiondVax just signed an exclusive worldwide license agreement with the Max Planck Society to develop and commercialize innovative NanoAb therapeutics for the treatment of psoriasis and psoriatic arthritis Part of an ongoing broad-based collaboration targeting therapies addressing diseases such as Covid-19, asthma, and macular degeneration Per BiondVax’s CEO, Amir Reichman, this exclusive license presents an exciting opportunity to develop a unique treatment for psoriasis BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products mainly for treating infectious and autoimmune diseases, just announced that it has signed an exclusive worldwide license agreement to develop…

ThursdayJun 22, 2023 9:45 am

Electronic Servitor Publication Network Inc. (XESP) Signs New B2B Client

Electronic Servitor Publication Network recently signed a client agreement with Investor Brand Network (“IBN”), providing access to its managed digital engagement and activation services The agreement seeks to enhance IBN’s growth by helping the company reach new target markets to promote its brands and content distribution network XESP provides digital engagement and activation solutions that use sophisticated data analysis and smart technology, providing client companies with the ability to maintain complete control of their content while creating meaningful relationships with new customers The company helps clients drive growth Electronic Servitor Publication Network (OTCQB: XESP), a growth-focused digital activation and engagement…

ThursdayJun 22, 2023 9:00 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Seeks to Restore Domestic Supply Chains Amid Expanding Graphite Market

Critical elements including graphite have become not only a necessity for economic prosperity but a national security concern for U.S. policymakers Graphite is key for the energy transition because of its role in the lithium-ion battery production for EVs, but the U.S. currently has no graphite production capacity Reflex Advanced Materials aims to build domestic production and purification of graphite seeking to sell this critical element at a very high price in a very purified form Critical minerals, such as cobalt, lithium, and nickel, have become more than fundamental building blocks for clean energy technologies and electric vehicle (“EV”) batteries;…

WednesdayJun 21, 2023 10:30 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Lays out Transformational ESG Program Guidelines

Eloro Resources has recently published its ESG program, the next step on its journey toward creating sustainable long-term value for its shareholders The policy lays out the company’s objectives within the fields of corporate governance, corporate social responsibility and environmental production Eloro Resources has increasingly looked to align its operations with the requirements of its growing stakeholder base The company is set to publish its inaugural ESG report in 2023 Mining companies are increasingly seeking to embed sustainability in the way in which they do business as well as across their corporate strategies. Similarly, Eloro Resources (TSX: ELO) (OTCQX: ELRRF)…

WednesdayJun 21, 2023 9:45 am

Audio Broadcast Details Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Achievements in Sustaining Domestic REE Production

Ucore Rare Metals Inc. is a critical metals process developer intent on establishing North American-based resources for rare earth element (“REE”) production The company has developed its trademarked RapidSX(TM) process for separating REEs from ore deposits, describing it as a faster and more environmentally friendly solution than the industry standard process Ucore regards the establishment of a North American-based supply chain for REEs as a critical need to maintain the industry’s independence from China-dominated sourcing and processing The U.S. Department of Defense recently awarded Ucore $4 million to demonstrate the capabilities of RapidSX(TM) A new NetworkNewsWire (“NNW”) audio broadcast and…

WednesdayJun 21, 2023 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Reveals Use of Lidar Technology in Texas & Utah Traffic Initiative; Announces Hire of Luis Gonçalves as Director of Customer Programs

Cepton recently revealed that its lidar technology has been deployed to bolster traffic infrastructure in Texas and Utah The announcement marks a continued trend, which has seen Cepton’s lidar solutions increasingly used to facilitate traffic management and smart city infrastructure – most recently announcing their multi-million contract with a leading U.S. tolling system operator With the company seeing growing business opportunities, as well as being fully committed to executing its flagship lidar series production program by a Top 3 automotive OEM, Cepton has looked to take the next step in its journey with the addition of Luis Gonçalves to its…

TuesdayJun 20, 2023 11:45 am

GolfLync Inc., the Social Media APP for Golfers, Garners Over 200 5-Star Reviews on the Apple App Store

GolfLync just received over 200 5-star reviews on the Apple App Store, performing exceptionally well in a space where sports apps averaged 3.97 and social networking apps posted a mere 3.73 in Q2 2022 The platform matches golfers of all skill levels looking for a game through its smartphone app, becoming the go-to social network for golfers The app’s warm reception is seen as a reflection of its exceptional user experience, made possible by the built-in logic that allows users to get the perfect match with whomever they share similar interests and on-course preferences GolfLync, offering a platform through its…

TuesdayJun 20, 2023 11:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapeutics

Biotechnology company BiondVax has entered into a collaboration with Max Planck Institute for Multidisciplinary Sciences (“MPG”) and the University Medical Center Göttingen (“UMG”) to develop innovative NanoAbs BiondVax enjoys an exclusive option for an exclusive worldwide license agreement at pre-agreed financial terms for additional NanoAbs discovered and characterized thereunder the RCA The company recently announced intent to develop innovative NanoAbs targeting immune system cytokines such as IL-17 for the potential treatment of psoriasis and psoriatic arthritis Analysts at Zacks Small-Cap Research laud the shift in focus to anti-IL-17 and have pegged the stock to reach $8 per share from current…

Site Search

Company Search

Category: News